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Abstract 
Background: Today, in the United States, 74,273 individuals are actively waiting for an organ 
transplant.  Of those, approximately 8,000 need a liver transplant. With the increased need for an 
organ transplant, the use of increased risk donors is on the rise.  In these patients, it is imperative 
to monitor for the transmission of HCV, HBV, and HIV.     
 
Purpose: Increase compliance for monitoring transplant recipients who receive organs from 
increased risk donors for HCV, HBV, and HIV. 
 
Design method: In order to measure the outcomes of this project, the following instruments were 
used: parametric testing and paired t-test.  Parametric testing was selected due to the ability to 
provide descriptive statistics from the data.  The paired t-test test data of two related groups at 
different points in time using pre/post-intervention. 
 
Conclusion: As a result, at two months, compliance of testing was 100%, and at one year, it was 
increased from 23.8% to 55.6%.  This indicates that using a phone call to remind patients was 
effective in compliance with testing. 
 
Keywords: liver transplant, increased risk donors 
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Improving patient follow-up for laboratory testing using telephone calls as an intervention: A 
Quality Improvement Project 
Introduction 
Today in the United States, 74,273 individuals are actively waiting for organ transplants 
(Organ Procurement and Transplantation Network, n.d.).  Of those, approximately 13,400 are 
waiting for a liver transplant (Organ Procurement and Transplantation Network [OPTN]).    The 
use of increased risk donors, determined by previous behavior or circumstances in the past 
twelve months, is one approach used to increase the supply to help meet the demand for organ 
transplantation (Pruett, Clark, & Taranto, 2017).   
The original guideline, from Center of Disease Control and Prevention (CDC) in 1994, 
only classified high-risk with human immunodeficiency transmission (Irwin et al., 2017).  In 
2013, The Public Health Service (PHS) expanded the guideline to include the transmission of 
viral infections.  The PHS (2013) provided updated guidelines to reduce the risk of hepatitis B 
virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) in increased 
risk donors (Seem, Lee, Umscheid, & Kuehnert, 2013, p. 248).  Using the nucleic acid test 
(NAT) to perform advanced testing, the window for identifying an infection, compared to 
serology testing, has decreased the risk of infection (OPTN/UNOS Briefing paper, 2017).  Using 
NAT on organ donors can identify an infection in a shorter time frame.  The testing can detect 
HCV, HBV, and HIV.  The HBV testing for detection is 20-22 days, HCV testing for detection is 
3–5 days, and HIV testing for detection is 3-5 days (OPTN/UNOS Briefing paper, 2017, p. 6).  
All organ recipients are tested postoperatively for these diseases.  For facilities, the challenge is 
monitoring the frequency and completion of the testing on the organ transplant recipients.  The 
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purpose of this project was to increase compliance for monitoring organ transplant recipients 
who receive a liver from an increased risk donor, for HCV, HVB, and HIV. 
Background 
Organ transplantation started in the eighteenth century.  Transplantation was performed 
on both humans and animals (OPTN).  There were many failures in the beginning of 
transplantation, including not living through the surgery or rejecting the organ shortly afterward.  
By the mid-twentieth century, successful transplants were accomplished.  The first successful 
liver transplant occurred in 1967 (OPTN).  Immunosuppression was developed in the 1970s and 
approved for commercial use in 1983 (OPTN).  This significantly changed the rate of survival 
for patients (OPTN).    
Today, as the waitlist for organ transplant continues to grow, the supply of donors does 
not meet the demand.  Since January 2019, 74,273 people are actively waiting for an organ 
transplant, and 16,167 transplants have been performed, using 7,743 donors (OPTN).  Donors 
who have had possible exposure to HCV, HBV, and HIV before death are considered an 
increased risk donor.  Recipients receiving an organ from an increased risk donor must be 
provided with education about the risks and consent to the organ prior to transplant.  The 
recipient will then be monitored with laboratory testing postoperative to monitor for possible 
transmission.  The risk of transmission in these patients is relatively rare, but can result in serious 
illness or death (OPTN/UNOS Briefing paper, 2017, p. 248).  
One ongoing challenge in the organ transplant field is the disproportionate number of 
donors to recipients (Meirelles et al., 2015, p. 149).  In 2018, 36,500 transplants were performed, 
from approximately 10,700 deceased donors and 6,900 living donors (OPTN).  The use of 
increased risk donors was not considered acceptable in the past, and therefore, was rejected by 
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transplant centers and recipients (OPTN/UNOS Briefing paper, 2017).  The guideline was 
changed to consider the use of organs otherwise be discarded (Irwin et al., 2017).  In 2013, the 
criteria for increased risk donors were changed and current calculations show 20% of all donors 
are increased risk donors (Pruett, Clark, & Taranto, 2017, p. 1670).  All donors are screened for 
activities considered to be at risk in the twelve months prior to their death.  The following actions 
are considered increased risk according to current criteria: men having sex with men (MSM), 
non-medical injection drug use, people who have sex in exchange for drugs or money, women 
who have sex with a man with a history of MSM, people who had sex with a person that injected 
drugs, people who have sex with a person known or suspected to have HIV, HBV, and HCV, 
people who have been in jail, hemodilution of the donor, and unknown history of the donor 
(OPTN/UNOS Briefing paper, 2017, p. 13-14). 
Organ recipients are educated on the benefits and risks of organ transplant, as well as the 
additional potential dangers associated with increased risk donors.  The education regarding an 
increased risk donor includes the likelihood of contracting one of the diseases, postoperative 
monitoring, and potential treatment if an infection is transmitted.  When the recipient is offered 
an increased risk donor, enough information sometimes is disclosed to optimize the recipients 
informed consent (U.S Department of Health and Human Services, 2013).  At this author's 
current employer, approximately 33% of organs transplanted have been from increased risk 
donors. 
Currently, in 2019, there are 74,419 patients actively waiting on the UNOS transplant list.  
There have been 16,167 transplants performed this year from 7,743 deceased and living donors.  
The deceased donors accounted for 4,781, with 1,332 considered increased risk donors (Organ 
Procurement and Transplantation Network).  Not every organ from increased donors is utilized; 
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it is estimated that 313 more transplants could be performed if centers and patients accept an 
increased risk donor (Volk, Wilk, Wolfe, & Kaul, 2017, p. 1668).  
 At this Doctor of Nursing Practice (DNP) author's current employer, the use of increased 
risk donors since January 2019 has been approximately thirty-three percent.  The hospital policy 
stated that laboratory testing was to be done postoperatively at month one, three, and twelve after 
transplant.  However, compliance for testing at the appropriate time was only 43% for laboratory 
testing at month one, 33% at month three, and 25% at month twelve.  Non-compliance with 
testing occurred because patients did not get the testing done, and the chart was not reviewed to 
confirm the completion of the testing.   With a lack of testing, there is potential that transmission 
of the illness may have occurred, and the patient is not receiving the necessary treatment.   
Problem Statement 
With the growing use of increased risk donors, appropriate monitoring of the recipient 
must be done in order to screen for possible transmission of HBV, HCV, and HIV.  The 
institution's previous policy stated that testing was three times in the first year after when a 
recipient received an increased risk donor organ (Appendix A).  The 2013 PHS guideline-
recommended testing only twice after transplantation of an increased risk organ.  In 2019, the 
center changed its policy to the PHS guideline (Appendix B). 
The transplant department is implementing a quality improvement project in the adult and 
pediatric kidney, liver, and heart centers, looking at the percentage of the testing being 
completed.  This author's performance improvement project was aimed at improving the 
compliance of laboratory testing of recipients who received increased risk donor using telephone 
calls as the intervention.  The project was limited to the liver transplant department, with 
possibility expanding to the organ transplant departments.  The project has the potential to 
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impact the future of nursing by aligning practice with current evidence-based guidelines and 
improving patient outcomes.  
PICO 
In liver transplant recipients who received an organ from an increased risk donor, how do 
phone calls, compared to no phone calls, impact the rate of compliance for postoperative 
laboratory testing? 
Organizational Description of Project Site 
This project was completed at a transplant center is at a 900-bed metropolitan medical 
center in the southeast region of the United States.  The transplant center performed 
approximately eighty liver transplants in 2018 and expected to meet or exceed this number in 
2019 at the initiation of this project.  Of these liver transplants, approximately 30% were 
received from increased risk donors.  At the transplant center, monitoring transplant recipients, 
who received an increased risk donor, for infectious diseases was to be at months one, three, and 
twelve after transplant.  The testing included HIV PCR, HCV PCR, HBV PCR, and HBsAg at 
months one, three, twelve, with additional testing at month twelve for anti-HBs and anti-HBc.  
When preparing for a United Network for Organ Sharing (UNOS) accreditation survey, the 
institution identified that the testing was not always completed, as the policy stated.  The 2013 
PHS guideline recommendations were adopted in the new policy (Appendix B). 
Review of the Literature 
Organ Transplantation 
Organ transplantation began in the eighteenth century by experimenting with animals and 
humans (Meirelles et al., 2015).  According to Meirelles et al., (2013), the first successful 
transplant was accomplished in 1967 with the use of antilymphocytic serum.  As years passed, 
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the development of immunosuppression medication was developed, increasing the survival rate 
of organ transplantation.  Since the first liver transplant, more than ten million liver transplants 
have been performed in the world with the survival rate for the first year roughly 80 – 90% 
(Meirelles et al., 2015). 
Guidelines 
In 1994, the PHS developed a guideline to prevent the transmission of HIV (Seem et al., 
2013).  Although it was rare, unexpected patient safety and health risks were identified.  Organ 
recipients experienced adverse outcomes related to the transmission of infectious diseases (Pruett 
et al., 2017).  Because of these adverse patient outcomes, the Organ Procurement and Transplant 
Network (OPTN) implemented the requirement for testing for HIV, HCV, HBV, 
cytomegalovirus, Epstein-Barr virus, and syphilis.   In 1994, the PHS identified specific 
behavior, exposures, or situations linked to increased risk (Pruett et al., 2017).  OPTN did not 
stipulate that recipients must be informed that the donor was an increased risk until 2008.   
In 2013, the PHS developed a new guideline with the primary objective of preventing the 
transmission of infections.  Preventing disease transmission may improve the outcome of the 
transplant recipient (Seem et al., 2013).   Even though this guideline was implemented to protect 
the recipients and increase opportunities for transplantation, once some recipients and/or 
transplant centers learn that the donor is considered to be at increased risk, the organs are 
continuing to be declined.   
Donors 
Region 11 of OPTN includes North Carolina, South Carolina, Kentucky, Virginia, and 
Tennessee (Organ Procurement and Transplantation Network, n.d.).  In 2018, there were 901 
deceased donors.  Of those donors, 282 were considered increased risk donors, based on OPTN 
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data as of June 24, 2019 (Organ Procurement and Transplantation Network, n.d.).  In 2019, from 
January 1 to June 30, 2019, the transplant center transplanted forty-six recipients; of those, 
fourteen received organs from increased risk donors.  Approximately 32% of the Transplant 
Center's transplants are from increased risk donors.  According to Sibulesky, Javed, Reyes, and 
Limaye (2015), in 2014, of the northwest organ procurement region's donors, twenty-six percent 
were increased risk.  Overall, the number of increased risk donors has steadily increased.  One 
potential reason for this is related to the increasing number of opioid overdoses in the United 
States (Abara et al., 2019, p. 64).  Outcomes, from average risk and increased risk donors, have 
been compared.  A study at Rush University Medical Center found the outcomes for 
transplantation of increased risk donors were similar to the average risk donor (Fleetwood, 
Lusciks, Poirier, Hertl, & Chan, 2016). 
This author's review of literature found a lack of data regarding outcomes using increased 
risk donors in liver transplantation.  For this reason, the search was expanded to include other 
solid organs.  Even though the use of increased risk donors is used at a lower rate, the outcome 
was comparable to the average risk donor (Gaffey et al., 2016).  According to Tsiouris, Wilson, 
Sekar, Mangi, and Yun (2016), the use of high-risk donors did not affect liver graft function.  
When addressing organ transplant consent from high-risk donors, education and a positive 
attitude from the recipient's physician were linked to increased consent from recipients (Tsiouris, 
Wilson, Sekar, Mangi, & Yun, 2016).  
Recipients 
In a study by Humar et al., (2019), the attitudes of recipients accepting an organ from an 
increased risk donor varied by demographic area, the education provided to the recipients, and 
the recipient's perception of increased risk behavior.  According to Humar et al., (2019), with 
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increased education regarding the risks and benefits of an increased risk donor organ, acceptance 
could increase by twenty percent.  According to Volk et al., (2017), approximately 313 
transplants per year could be performed if the label of increased risk donor was not used.  Based 
on these findings, additional education to patients and providers may increase the use of 
increased risk donor organs (U.S Department of Health and Human Services, 2013: Volk et al., 
2017). 
Testing 
According to Irwin et al. (2017), in 2016, 34% of all donors were considered to be 
increased risk.  Most of these donors are young adults from 19-34 years of age with viable, 
healthy organs.  In a retrospective review of 257 transplant recipients, it was identified that 29% 
of recipients at one to three months, and 17% at six to twelve months, missed the scheduled 
follow-up testing (Irwin et al., 2017).  Even though the labs were missed at the scheduled times, 
they were completed.  None of these recipients developed HCV, HIV, or HBV transmission 
documented by NAT testing (Irwin et al., 2017). 
Compliance of follow-up 
Patient compliance for follow-up is always a concern in healthcare.  According to 
Kumthekar and Johnson (2018), a simple phone call reminder significantly improved show rates 
for clinic appointments.  A research study by Callinan et al. (2015) identified, in a specialty eye 
clinic, performing personal follow-up phone calls increased appointment compliance when 
compared to automated calls.  This author's project is to identify of follow-up phone calls with 
increase compliance for obtaining the needed laboratory testing.  
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Summary 
In the literature, it was identified that approximately one-third of donors are considered to 
be increased risk.  Even though the need for organ donation is high, the supply remains scarce.  
Although increased risk donors are serving to help meet the supply, recipients and transplant 
centers continue to decline increased risk organs.  More studies in this area are needed.  Limited 
current data suggest that transmission rate using increased risk donors are similar to other 
transplants.  This information demonstrates promise for the future of liver transplant patients.  At 
this DNP author's transplant center, 33% of the recipients agree to accept an increased risk 
donor.  For patient safety and positive outcomes, it is imperative that testing occurs for 
monitoring the transmission of infectious diseases.  
Evidence-Based Practice: Verification of Chosen Option 
During the review of charts in the spring of 2019, before the UNOS accreditation, it was 
identified that the current policy was not being followed.  After review of the PHS guideline, it 
was also identified that the transplant center was not following the most current recommendation 
from the CDC.  The updated policy was implemented on July 1, 2019 (Appendix B). This DNP 
author implemented a laboratory follow-up intervention using a phone call intervention.  
Theoretical Framework/Evidence-Based Practice Model 
Implementing evidence-based practice by using a model or framework helps to outline 
the process used for project development (Moran, Burson, & Conrad, 2017, p. 133).  This author 
used the Iowa model revision for the project.  The Iowa model revised is used as a guide for the 
implementation of evidence-based practice (Iowa Model Collaborative, 2017).  This author 
contacted the University of Iowa Hospital and Clinics for permission for the use of the model.  
(Appendix C) Used/reprinted with permission from the University of Iowa Hospitals and Clinics, 
IMPROVING PATIENT FOLLOW-UP FOR LABORATORY TESTING 16 
copyright 2015.  For permission to use or reproduce, please contact the University of Iowa 
Hospitals and Clinics at 319-384-9098.   
The Iowa model revised uses an algorithm to follow (Iowa Model Collaborative, 2017).  
Saqe-Rockoff, Schubert, Ciardiello, and Douglas (2018), used the Iowa model to provide a 
framework for execution and evaluation for a project regarding thermoregulation in trauma 
patients.  By using this model, an interdisciplinary team looked at triggers for issues and 
opportunities, identifying priority to emergency departments and the trauma program.  A 
literature review was completed to gather relevant data to warrant a practice change.  From this 
discovery, the policy and protocols were updated.  Email and daily huddles dispersed policy, 
protocol, and education to the staff.  The data was analyzed, and the results disseminated.  Thus, 
the Iowa Model provided structure and guidance for implementation of evidence-based practice.    
Goals, Objectives and Expected Outcomes 
The purpose of this project was to increase compliance for monitoring organ transplant 
recipients who receive a liver from an increased risk donor, for HCV, HVB, and HIV, twice 
instead of three times.  The CDC recommends monitoring organ recipients for transmission of 
these illnesses after receiving an increased risk donor organ between month one and three and 
then again at month twelve.  However, for this facility, statistical data indicates that 30% of the 
patients fail to meet the criteria for follow-up lab monitoring.  In order to improve compliance, 
an intervention of phone calls prior to the lab appointment were implemented.    The phone calls 
were at one week and one day before the scheduled lab appointment. 
The goals, objective, and the expected outcome 
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• Specific – Organ recipients who receive a liver transplant from an increased risk 
donor would get the required laboratory monitoring to detect if transmission of 
HCV, HBV, or HIV occurred. 
• Measurable – Laboratory testing was initiated postoperatively at months two and 
twelve, allowing a thirty-day window before or after the respective date.  The 
expected outcome was that all patients who received a liver transplant from an 
increased risk donor would have the appropriate testing one hundred percent of 
the time.  
• Assignable – The DNP author planned to call the patients one week prior to the 
scheduled labs and then again one day prior to the date for the laboratory testing.  
The laboratory orders would be placed electronically in the EHR, following 
protocol for patients who received an organ from an increased risk donor.   The 
laboratory results would be monitored to ensure the test was completed.  The 
results were documented in an Excel spreadsheet in the transplant centers quality 
database.  
• Realistic – It was estimated that there will be approximately twenty-five patients 
in this project who receive a liver transplant from an increased risk donor.  This 
estimate was developed by looking at past information within our transplant 
center.   
• Time-Specific – The new policy went into effect August 2019.  Patients needing 
laboratory testing from October 2019 until April 2020 would be monitored for 
compliance with the testing being completed.   The monitoring was for two-
month testing and twelve-month testing. 
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Project Design 
This project was a process improvement project using a quantitative method.  Throughout 
the project, the completion of laboratory results was monitored to identify compliance.  The 
project was monitoring whether or not the required laboratory testing was completed at the two-
month and twelve-month interval.  Phone calls before the scheduled appointment were 
implemented in order to increase compliance. 
Project Site and Population 
The project was conducted in an academic medical center located in a metropolitan area 
of the Southeastern region of the United States.  The health system consists of forty hospitals and 
nine hundred care locations.  UNOS accredits the transplant center, liver, kidney, liver/intestine, 
and heart transplants are performed at the medical center.  The project was focused on patients 
who have end-stage liver disease and who received a liver transplant from an increased risk 
donor.   The center's team consists of liver transplant surgeons, hepatologists, advanced practice 
providers, transplant coordinators, patient assistants, social workers, dietitians, and pharmacists.  
The team for the project consisted of a registered medical assistant (RMA) and this author.  Only 
the adult liver transplant patients who received an organ from an increased risk donor were 
described in this process improvement project.    
Setting facilitators and barriers 
After a liver transplant, the patients are scheduled for follow-up with return 
appointments.  The appointments are scheduled at the time of discharge, so the patient is aware 
of the dates for the return appointments.  Some patients live as far as four hours from the clinic.  
The distance may impact compliance with return appointments.  This author called the patients 
in hopes that this would assist with compliance for follow-up of the required laboratory testing.   
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The barriers included not being able to reach the patient by telephone, and the patient not 
keeping the scheduled appointment.   
Implementation Plan/Procedures 
During chart reviews from July 2018 to December 2018, completed in the spring of 2019, 
a discrepancy was revealed regarding reduced patient compliance rates with post-transplant 
required blood work.  The team reviewed the facility policy and current literature for best 
practice related to testing transplant recipients to monitor for any disease transmission from an 
increased risk donor to the recipient.  After the literature review, it was decided by the 
administrative team of the facility to follow the Center of Disease Control (CDC) guideline for 
PHS increased risk donors.  This author updated the policy.  It was then presented at the quality 
performance improvement committee with implementation on August 1, 2019.  With the updated 
policy, this author implemented the intervention of phone calls to any recipient who received a 
liver transplant from an increased risk donor to increase the compliance rate of laboratory 
testing.  This author kept the quality improvement project excel spreadsheet of the recipients 
who received a liver from an increased risk donor, when the testing needs to be completed, and 
completion of the testing.  The phone calls and completion of the laboratory testing were 
documented on the excel spreadsheet.  
Measurement Instrument 
In order to measure the outcomes of this project, the following instruments were used: 
parametric testing and paired t-test.  Parametric testing was selected due to the ability to provide 
descriptive statistics from the data (Sylvia & Terhaar, 2014).   According to Sylvia & Terhaar 
(2014), the paired t-test test data of two related groups at different points in time using pre / post-
intervention.  Pre-intervention data was collected from January to July 2019, to identify 
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compliance of laboratory testing.  The project ran from October 2019 to April 2020.  The 
compliance rate of laboratory results was compared to the results prior to the implementation of 
follow up phone calls.   
Data Collection Procedures  
The patients who received an organ from an increased donor were queried from the liver 
transplant quality database.  Data was collected and deidentified, allowing for the patients to 
remain anonymous.  The data was deidentified by using a number sequence of the patients in 
consecutive order not including their name or date of birth.  This author called the patients one 
week prior to and one day prior to the scheduled laboratory testing.  The orders for the laboratory 
testing were entered into the EHR by this author.  The charts were reviewed for compliance with 
the testing.  If the patient did not come to the follow-up appointment, this author called the 
patient to reschedule.   Pre-intervention, the phone call post-intervention, and completion of 
laboratory results was entered into an excel spreadsheet.  Percentages were compared to see if 
the phone calls improved compliance. 
Data Analysis 
Creating evaluation and process measures are crucial in determining the success of this 
project.  The data was quantitatively analyzed, comparing the adherence of completed laboratory 
testing.  The comparison was the pre and post-intervention; the intervention was a notification by 
phone call for the upcoming laboratory testing.   Phone calls were documented in an excel sheet, 
as well as whether or not the laboratory testing was completed.      
Cost-Benefit Analysis/Budget 
There was not a cost-benefit analysis budget required for this project.   This author was 
authorized to work on this project as part of her work assignment.   The benefit for the liver 
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transplant recipient is to identify if a viral illness was transmitted from an increased risk donor.  
Identification of a transmitted viral infection promptly will allow for treatment without causing 
illness to the recipient or damage to the transplanted liver.   
Literature was limited with the benefit for using an increased risk donor versus a non-
increased risk donor as well as the average cost for the recipient that is transmitted a viral illness 
from an increased risk donor.  Future research is needed to investigate the cost to a patient who 
develops a viral illness from the donor versus the quality of life, not using an increased donor.  
An article by Mulvihill et al. (2018) did identify thru a retrospective data review of heart 
transplant recipients at Duke University Medical Center, those recipients who accepted an 
increased risk donor provided a significant and clinically meaningful survival benefit. 
Timeline 
The project was submitted to the facility's Institutional Review Board as well as the 
Jacksonville State University Institutional Review Board for approval before the starting of this 
project.  The project occurred between the periods of October 2019 and continued until the end 
of April 2020.  An excel spreadsheet contained when the phone calls happened if the patient was 
reached one week prior to and again one day prior to the scheduled laboratory testing and if the 
laboratory testing was completed.   The documentation included whether or not the patient was 
reached if a voice mail was left, and if the patient was not able to be reached.  The data collection 
was completed at the end of April 2020.  See Appendix D for a table of the timeline.  
Ethical Considerations/Protection of the Human Subjects 
The Jacksonville State University and the facility's Institutional Review Board (IRB) 
approval was obtained before initiating the DNP project.  All participants were protected by the 
Health Insurance Portability and Accountability Act of 1996 (HIPPA), which protects the 
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privacy of the patients' health information (U.S. Department of Health and Human Services, 
2019).  HIPPA sets standards that protect all individual's identifiable health information or 
protected health information, thus giving individuals' rights to understand and control how their 
information is being used (Sylvia & Terhaar, 2014, p. 65). 
Additionally, this author followed the Standards of Care for practice in the liver 
transplant office.  Participant confidentiality was assured by coding the participant using specific 
identification numbers.  The participants were coded using a numeric system.  The original 
document linking the participant to the numeric number was stored on a USB drive that was 
password protected and stored in a locked filing cabinet.  The filing cabinet was located in this 
author's office, and only this author had the key to the filing cabinet. 
Conclusion/ Analysis 
A study was conducted to show whether using a phone call intervention positively 
impacted the rate of compliance for monitoring transplant recipients who receive organs from 
increased risk donor for HCV, HBV, and HIV for the 2-month and 12-month lab testing.  Since 
the pre-data has shown that the response was very low for getting laboratory testing completed, a 
new policy was implemented.  For the project, this DNP author reminded patients of his or her 
upcoming appointment through phone calls, 1 week, and 1 day prior to their appointment.  For 
this quality improvement project, twenty-one patients were evaluated from 2018 before the new 
policy was in effect, and 34 patients were followed from 2019-2020 after the policy began. 
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The patients in this study consisted of 22 female patients (40%) and 33 male patients (60%).  
Forty-six patients out of 55 (83.6%) were of the Caucasian race, six patients out of 55 (10.8%) 
were African American, and the remaining patients (5.5%) were other ethnicities.            
 
 
83.6%
White
5.5%
other
10.9%
Black
Overall Breakdown of Patients by Ethnicity
60.0%
Male
40.0%
Female
Overall Breakdown of Patients by Gender
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Overall, 44 patients (80%) were also listed as diabetic, and 11 patients (20%) did not 
have diabetes at the time of transplant.   
 
Only 1 patient (3.6%) had received any previous treatment for liver failure, a prior liver 
transplant. 
 
20.0%
Yes
80.0%
No
Overall Breakdown of Patients by Diabetes Diagnosis
3.6%
One
96.4%
None
Overall Breakdown of Patients by Previous Treatment
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This sample data had a wide range of education level.  Four patients (7%) reported a 
grade school education, 10 patients (18%) reported a high school education, 14 patients (25%) 
reported receiving some college or technical degree, 15 patients (27%) reported receiving an 
associate or a bachelors degree, and 1 patient (2%) reported receiving a graduate degree.  No 
level of education was reported for 11 patients (20%).   
 
Some other demographic factors are presented in the table below: 
Patient Information 2018 2019/2020 
Mean Age 55.4 (SD = 9.4) *** 
Mean BMI 28.6 (SD = 6.2) 31.4 (SD = 6.6) 
Mean MELD Score 18.7 (SD = 9.5) 25.8 (SD = 11.0) 
 
Insurance   
Medicare 19% *** 
Medicaid 43% *** 
Private 38% *** 
 
Blood Type   
A 33% 44% 
B 14% 12% 
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AB 5% 0% 
O 48% 44% 
 
Donor Information   
Mean Donor Age 31.3 (SD = 11.2) 33.6 (SD = 11.0) 
Mean Donor Weight (kg) 80.3 (SD = 20.4) 83.6 (SD = 20.4) 
Mean Donor Height (cm) 172.2 (SD = 8.6) 174.6 (SD = 9.9) 
 
Donor Blood Type   
A 19% 35% 
B 10% 6% 
AB 19% 9% 
O 52% 50% 
 
Donor Ethnicity   
Caucasian 71% 65% 
African American 24% 26% 
Other  5% 9% 
***Data not collected 
A comparison of patients who had 1-month and 3-month lab tests before the new policy 
versus those who completed 2-month labs after the new policy was conducted.  The result 
revealed that there was a significant increase in the percentage of patients who completed 2-
month labs when compared to the percentage of patients who had 1-month labs performed.  Only 
6 out of 21 patients (28.6%) had lab tests completed 1-month post-transplant with no telephone 
reminders, while all 14 patients who were reminded with phone calls attended his or her lab 
testing 2 months post-transplant (z = -4.18, p <0.001).  However, no significant difference was 
detected between the percentage of patients who had lab test 3-months post-transplant with no 
phone call reminders when compared to the proportion of patients who had lab test 2-months 
post-transplant with telephone reminders (z = -3.97, p <0.001). There were 9 out of 21 patients 
(42.9%) present at his or her 3-month post-transplant follow-up before the new policy began, and 
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all 14 out of 14 (100%) patients were present at his or her 2-month post-transplant follow-up 
after the new policy began.  
 
 
Additionally, compliance rates for patients at his or her 12-month post-transplant follow-
up are as follows.  For patients, before the new policy was implemented, 5 out of 21 (23.8%) 
were present for his or her 12-month lab tests.  Once the new policy was in effect, 5 out of 9 
(55.6%) of the patients followed in 2019/2020 were present for his or her 12-month lab tests. 
Fisher's Exact test of proportions indicated there was no significant increase in the compliance 
rate for patients who received phone call reminders of appointments (p =0.115).  There is no 
evidence that the new policy results in a greater percentage of patients having lab tests completed 
12-months post-transplant.  Limitations with the 12-month data also included that of the four 
patients that did not get labs, one died, one was re-transplanted, one transferred to be followed by         
an outside hepatologist, and one did not get labs completed.  
 
2-month3-month1-month
noyesnoyesnoyes
100
80
60
40
20
0
71.4%
28.6%
57.1%
42.9%
0.00%
100%
Percent is calculated within variables.
Comparison of Lab Test Compliance
First Follow-up
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The purpose of the DNP quality improvement project was to improve patient follow-up 
for laboratory testing.  The project showed statistical significance at 2-month but not at 12-
month, although there was improvement.  Since there was an improvement in the completion of 
laboratory testing for recipients who received an increased risk donor, a sustainable plan must be 
developed moving forward.  The results were discussed at the quality improvement meeting for 
liver transplant and will be disseminated to the other transplant programs.  
  
AfterBefore
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Appendix A 
CAROLINAS MEDICAL CENTER 
CLINICAL PRACTICE 
Transplant Center 
 
 
Protocol for Recipients of Increased Risk Donor Organs 
 
 
I. Purpose 
 
In accordance to the United States Public Health Services, transplant recipients of an 
organ from a donor who has been identified as increased risk for disease transmission of 
HIV, Hepatitis B, and Hepatitis C need to have monitoring pre and post-transplant. 
 
 
II. Procedure 
 
1. The following laboratory studies are to be drawn on the recipients during the 
hospital admission for the organ transplant PRIOR to organ implantation and 
at POSTOPERATIVE months 1, 3, and 12: 
a. HIV PCR  
b. HCV PCR  
c. HBV PCR   
d. HBsAg  
 
2. The additional following laboratory studies are to be drawn on the recipients 
at POSTOPERATIVE month 12: 
a. Anti-HBs 
b. Anti-HBc  
c. HBsAg 
 
 
 
______________________________ ________________________ 
 
Medical Director     Date / Time 
 
Reviewed 1/17 
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Appendix B 
CAROLINAS MEDICAL CENTER 
CLINICAL PRACTICE 
Transplant Center 
 
 
Protocol for Recipients of Increased Risk Donor Organs 
 
I. Purpose 
 
In accordance to the United States Public Health Services, transplant recipients of an organ from 
a donor who has been identified as increased risk for disease transmission of HIV, Hepatitis B, 
and Hepatitis C need to have monitoring pre and post-transplant. 
 
II. Procedure 
 
3. The following laboratory studies are to be drawn on the recipients during the hospital 
admission for the organ transplant PRIOR to organ implantation  
a. HIV PCR (HIV viral load by Polymerase Chain Reaction) 
b. HCV PCR (HCV viral load by Polymerase Chain Reaction) 
c. HBV PCR (HBV viral load by Polymerase Chain Reaction)  
d. HBsAg (Hepatitis B Surface Antigen) 
 
4. The following laboratory studies are to be drawn on the recipients POSTOPERATIVE 
month 2: allow for a 30-day window before or after. 
a. HIV PCR (HIV viral load by Polymerase Chain Reaction) 
b. HCV PCR (HCV viral load by Polymerase Chain Reaction) 
c. HBV PCR (HBV viral load by Polymerase Chain Reaction)  
d. HBsAg (Hepatitis B Surface Antigen) 
 
5. The following laboratory studies are to be drawn on the recipients at 
POSTOPERATIVE month 12: allow for a 30-day window before or after. 
a. HIV PCR (HIV viral load by Polymerase Chain Reaction) 
b. HCV PCR (HCV viral load by Polymerase Chain Reaction) 
c. HBV PCR (HBV viral load by Polymerase Chain Reaction)  
d. HBsAg (Hepatitis B Surface Antigen) 
e. Anti-HBs (Hepatitis B Surface Antibody) 
f. Anti-HBc (Total Hepatitis B Core Antibody) 
 
 
 
 
 
______________________________ ________________________ 
 
Medical Director     Date / Time 
 
Reviewed 7/19 
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Appendix C 
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Appendix D 
 
 
  2019 2020 
Timeline of Events Aug Sept Oct Nov Dec Jan Feb Mar April May June July 
Engage JSU Faculty                         
Engage Stakeholders                         
Organizational IRB 
Approval                         
JSU IRB Approval 
for the project                         
Generate Pre-
Implementation 
Report                         
Implement Project                         
Collect Data                          
Enter Data                         
Generate Post-
Implementation 
Report                         
Analyze/Interpret 
Data                         
Written and Oral 
Presentation                         
Graduation                          
 
